Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $422,336 - $484,097
-3,633 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $408,966 - $466,586
3,633 New
3,633 $453,000
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $312,838 - $375,935
-3,946 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $3.03 Million - $3.38 Million
-36,256 Reduced 90.18%
3,946 $361,000
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $3.21 Million - $3.59 Million
40,202 New
40,202 $3.43 Million
Q1 2018

May 15, 2018

SELL
$71.51 - $84.69 $231,191 - $273,802
-3,233 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $204,454 - $235,362
3,233
3,233 $233,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.